Stride, Inc. (LRN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN). Investors who purchased Stride securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Stride has violated federal securities laws.
Investigation Details
On October 16, 2024, Fuzzy Panda Research published a report on Stride alleging that the Company inflated its earning by misleading the market about COVID-19 relief funds. The report claims that 25% of the Company’s EBITDA came from Elementary and Secondary School Emergency Relief (ESSER) funds expiring in September 2024. Following this news, Stride stock dropped on that same day.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Stride securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]